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Background: Catechins-rich oil palm (Elaeis guineensis) leaves extract (OPLE) is known to have antioxidant activity.
Several polyphenolic compounds reported as antioxidants such as quercetin, catechins and gallic acid have been
highlighted to have pro-oxidant activity at high doses. Therefore, the present study was conducted to investigate
the antioxidant and pro-oxidant effects of chronically administering high dose of OPLE (1000 mg kg-1) in an animal
model of diabetic nephropathy (DN).
Methods: Animal body weight, indexes of glycaemia, renal function and morphology were assessed in diabetic
animals with and without OPLE (1000 mg kg-1) for 4 and 12 weeks respectively. Oxidative stress was quantified by
measuring levels of 8-hydroxy-2’-deoxyguanosine (8-OHdG), lipid peroxides (LPO) and reduced glutathione (GSH).
Transforming growth factor-beta1 (TGF-β1), a key mediator of extracellular matrix accumulation, was analysed in
plasma. The mechanisms of OPLE action were evaluated by assessing nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase subunits (p22phox and p67phox) expression.
Results: Oral administration with high dose of catechins-rich OPLE (1000 mg kg-1) to STZ-induced diabetic rats for
4 weeks attenuated renal dysfunction (hyperfiltration, proteinuria) and development of glomerulosclerosis and
tubulointerstitial fibrosis, features that are associated with DN. Suppression of increases in oxidative stress markers
(8-OHdG, LPO) and the fibrotic cytokine, TGF-β1 was observed. OPLE also reduced renal expression of NADPH
oxidase subunits p22phox and p67phox. In contrast and surprisingly, identical dose of OPLE when administered to
diabetic animals for 12 weeks caused worsening of renal dysfunction, histopathology in addition to further
elevation of oxidative stress marker (LPO) and TGF-β1. These unfavourable effects of prolonged treatment with
1000 mg kg-1 OPLE were accompanied by increase expression of one of the NADPH oxidase subunits, p22phox.
Conclusion: Our study indicates that chronic administration of 1000 mg kg-1 OPLE exerts both antioxidant and
pro-oxidant effects in DN depending on the duration of treatment. The present study also reveals that the
antioxidant/pro-oxidant effects of OPLE are in part, due to modulation of NADPH activity.
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The balance between the production of reactive oxygen
species (ROS), notably superoxide anion (O2
-) and hy-
drogen peroxide (H2O2), and the antioxidant defence
system that includes superoxide dismutase (SOD) and
glutathione (GSH), is believed to be vital in maintaining
healthy biological systems. Indeed the balance between
oxidation and anti-oxidation which determines the de-
gree of oxidative stress is disrupted by disease state. Ex-
perimental and clinical evidence indicates that oxidative
stress may contribute to the initiation and development
of diabetic nephropathy (DN) [1-4] and in support, pre-
vious study in our laboratory also provided evidence for
in vivo oxidative stress in kidney of diabetic rats that was
accompanied by renal dysfunction such as glomerular
hyperfiltration and proteinuria; and structural damage that
included glomerulosclerosis and tubulointerstitial fibrosis
[5]. In the diabetic state, chronic hyperglycaemia can acti-
vate multiple pathways that lead to increased generation
of O2
- and other ROS; some of these pathways include en-
hanced activity of the mitochondrial electron transport
chain [2], increased expression and uncoupling of endo-
thelial nitric oxide synthase [6] and activation of the re-
duced forms of nicotinamide adenine dinucleotide
phosphate (NADPH) [7,8]. The latter system is present
abundantly in the renal vessels and in the glomerular
mesangial and podocyte cells, the macula densa, and the
thick ascending limb, distal tubule, and collecting ducts
[7]. Moreover, the renal expression of NADPH oxidase
has been shown to be enhanced in an animal model
of DN [9].
Strategies that reduce oxidative stress and/or increase
the activity of antioxidant defence mechanism can there-
fore attenuate hyperglycaemia-induced renal injury such
as in DN. Oil palm (Elaeis guineensis) leaves extract
(OPLE) is rich in catechins and these polyphenolic com-
pounds are considered to have antioxidant activity that
is several folds higher than that of vitamins C and E
[10]. We have demonstrated that oral administration of
OPLE (200 mg kg-1, 500 mg kg-1 administered daily
over a period of 4 and 12 weeks respectively) improved
renal function and prevented kidney structural injury
in rats with streptozotocin-induced diabetes. We as-
cribed the beneficial effects of OPLE in DN to its anti-
oxidant effect given that OPLE suppressed the elevation
of oxidative stress markers and improved antioxidant
defences [5].
Although the antioxidant capacity of phytochemicals is
well recognised [11,12], they can also in contrast, display
pro-oxidant activities under certain conditions, such as
at high doses or in the presence of metal ions. For certain,
the pro-oxidant or antioxidant activity very much depends
on their concentration. Several polyphenols previously
known as antioxidants such as quercetin, catechins andgallic acid have been highlighted to have pro-oxidant ac-
tivity at high doses [13-16]. For instance, the antioxidant
activity of quercetin was observed only at low doses (0.1 –
20 μM) while higher doses (50 μM) potentiated O2
-
generation within isolated mitochondria and cultured
cells [14,15]. It is with this knowledge that prompted
us to investigate whether high concentration of OPLE
(1000 mg kg-1) administered over a period of 4 and
12 weeks respectively to rats with streptozotocin-induced
diabetes, nonetheless maintains its antioxidant effect in
DN in the same way as in our previous study which
utilised lower doses of the extract (200 mg kg-1 and
500 mg kg-1 respectively). On the other hand, we do not
exclude the possibility that high dose of OPLE, depending
on the duration of treatment, may perhaps aggravate oxi-
dative stress in our animal model of DN. To test the above
hypothesis, we assess the effect of treatment with
1000 mg kg-1 of OPLE on animal body weights, indexes of
glycaemia, renal function and morphology. We establish
the extent of oxidative stress and the modulation of this
parameter by OPLE by measuring levels of 8-hydroxy-2’-
deoxyguanosine (8-OHdG), lipid peroxides (LPO) and
GSH. Further, we elucidate the mechanisms by which
OPLE exert its antioxidant effect or its aggravation of oxi-
dative stress in DN.Methods
Chemicals
Standardised ethanol extract of oil palm leaf extract
(OPLE) was obtained from Nova Laboratories, Malaysia
(Batch no: WH 1446). Antibodies recognising NADPH
oxidase subunit p22phox and β-actin were purchased
from Santa Cruz Biotechnology (USA). Antibodies recog-
nising NADPH oxidase subunit p67phox was procured
from Gene Tex (USA). Enzyme-linked immunosorbent
assay (ELISA) for the determination of glutathione (GSH),
lipid peroxides (LPO) and 8-hydroxy-2-deoxy guanosine
(8-OHdG) were obtained from Cayman Chemicals (Ann
Arbor, MI, USA). ELISA kit for the determination of
transforming growth factor-beta 1 (TGF-β1) was obtained
from Abnova (Walnut, USA). Streptozotocin (STZ) was
purchased from Sigma-Aldrich (St. Louis, MO, USA).
Immunohistochemical stains were obtained from Dako
(Baltimore, MD, USA). All other chemicals and solvents
were of analytical grade and were obtained from com-
mercial suppliers in Malaysia.Preparation of OPLE
Ethanolic fraction of oil palm leaves was prepared by the
manufacturers as described in our previous study [5].
According to the manufacturer report, 1.1% (−) catechin
gallate and 1.5% ferulic acid were present in the powder
extract.
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All experimental procedures were approved and com-
plied with the Guidelines of the Care and Use of Labora-
tory Animals at University of Malaya in Kuala Lumpur
(FAR/20101106/NAA-R). Male Sprague–Dawley rats
weighing 270–330 g were acclimatized (under controlled
conditions of 12 h light : dark cycle and at 21-25°C) for
1 week before the study and the rats were allowed unre-
stricted access to standard rat pellets and tap water dur-
ing the entire study period. Animals were randomly
divided into three groups for the 4-week or 12-week
studies (n = 10-15 per group) namely control (C), dia-
betes control group (DC), diabetes group treated with
OPLE at a dose of 1000 mg kg−1 (D +OPLE 1000). A
single intraperitoneal (i.p.) injection of STZ at a dose of
60 mg kg−1 was administered to induce diabetes which
was dissolved in freshly prepared 0.9% sodium chloride
(pH 4.5). Control rats received an equal volume of 0.9%
sodium chloride by i.p. injection. Diabetes was con-
firmed after 72 h by measuring blood glucose levels with
the use of glucose oxidase reagent strips (one touch
glucometer, Accu Chek) and those rats with a random
blood glucose level of >12 mmol l−1 were selected for
the study. After confirmation of diabetes, the rats were
treated with 1000 mg kg−1 OPLE which was dissolved in
distilled water given daily for either 4 or 12 weeks by oral
administration. Age matched control and diabetic control
group rats did not receive any OPLE treatment for the 4-
week or 12-week study. Blood glucose level was measured
in all groups twice in a week. On the 4th week, the per-
centage of survivors amongst the C, DC and D +OPLE
1000 mg kg−1 were 100%, 80% and 90% respectively. On
the 12th week, the percentage of survivors amongst the C,
DC and D +OPLE 1000 mg kg−1 were 100%, 70% and
75% respectively. At the end of the 4-week or 12-week pe-
riods, the rats were anaesthetised with sodium pentobar-
bital (60 mg kg−1, i.p.) for the renal functional study.
Surgical preparation and functional studies
A tracheostomy was performed to facilitate respiration.
The left jugular vein and carotid artery were cannulated
for anaesthetic infusion (12.5 mg kg−1 h−1 at 3 ml h−1 in
140 mM NaCl) and arterial pressure recordings (Power
Lab Systems and pressure transducer, AD Instruments)
respectively while the left femoral artery was cannulated
for blood sample collection. The left kidney was exposed
via a flank incision and a catheter was placed in the
urinary bladder for urine collection. An electromagnetic
flow probe was placed on the renal artery for renal blood
flow (RBF) measurement (Carolina Square-wave Electro-
magnetic flowmeter and EP 100 series probe; Carolina
Medical, NC, USA). Inulin (10 mg ml−1) was included in
the infusate. Thereafter, a 2 ml priming dose solution
(10 mg ml−1 inulin in 140 mM NaCl) was administeredto the rats via the jugular vein and allowed an hour as
equilibration period. Thereafter, four 30 min clearances
(urine) were collected and frozen at −20°C till subse-
quent analysis. Arterial blood samples were collected at
the beginning and at the end of every two clearances.
The blood samples were centrifuged and plasma was
frozen at −20°C till subsequent analysis. At the end of
the study, the rat was sacrificed by rapid intravenous in-
jection of 1 ml sodium pentobarbital (60 mg kg−1) and
the right kidney was harvested, dissected into cortex and
medulla, and snap frozen in liquid nitrogen for measure-
ment of GSH, LPO, NADPH oxidase subunits p22phox
and p67phox. The left kidney was perfused first with
ice-cold phosphate buffered saline until cleared off blood
and then fixed with 10% formalin for histopathological
screening.
Biochemical analysis
Urinary protein concentration was determined by biuret
reagent according to the method developed by Doumas
et al. [17]. Urine and plasma sodium concentrations
were analysed by using a flame photometer (Sherwood,
Model 420, UK) and urine volume was measured gravi-
metrically. Inulin content in urine and plasma samples
were determined according to the method developed by
Somogyi et al. [18] after the samples were deproteinised
according to the method proposed by Bojesen et al. [19].
Glomerular filtration rate (GFR) was equated with renal
clearance of inulin and was expressed as ml min−1 g−1 of
kidney weight.
Urinary excretion of 8-OHdG
8-OHdG is one of the most common markers for oxida-
tive DNA damage and oxidative stress in vivo. ELISA kit
from Cayman Chemicals was used to measure 8-OHdG
levels in 2 h urine samples. The 8-OHdG standards (0.5-
80 ng ml−1) and 35–50 μl of urine were allowed to incu-
bate separately for 1 h in a microtiter plate precoated
with 8-OHdG. After washing the antibodies, enzyme-
labelled secondary antibody was added and incubated
for 1 h followed by washing. The colour that developed
by the addition of 3, 3’, 5, 5’–tetramethylbenzidine was
measured at 450 nm using a spectrophotometer. Urinary
8-OHdG was expressed as total amount excreted in 2 h.
Reduced glutathione in kidney
Cytosolic reduced GSH in renal cortex homogenates was
measured using a glutathione assay kit from Cayman
Chemicals according to the manufacturer’s protocol. The
sample (100–150 μg) was deproteinised using metaphos-
phoric acid, and the intensity of the yellow colour pro-
duced by 5-thio-2-nitrobenzoic acid in the supernatant
liquid was measured at 410 nm using spectrophotometer
(UV/VIS λ, Perkin Elmer, USA).
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Lipid peroxides (LPOs) in the renal cortex were mea-
sured colourimetrically at 500 nm using Cayman’s assay
kit. Briefly, renal cortex was homogenised in HPLC-
grade water and LPOs were extracted from the homoge-
nates according to the manufacturer’s protocol. LPO
were measured directly by redox reactions with ferrous
ions using the kit, and the resulting ferric ions were
detected using thiocyanate ion as the chromogen.Plasma transforming growth factor-beta 1 (TGF-β1)
The frozen plasma samples collected from the arterial
blood of experimental animals on the 4th and 12th week
were analysed for TGF-β1 using ELISA kit as previously
described [5]. Plasma TGF-β1 is expressed as total
amount excreted in pg ml−1.Histopathological study
Tissue samples were collected at necropsy. After forma-
lin fixation, renal tissues were processed using an auto-
mated tissue processing machine and finally embedded
in paraffin. Subsequently, tissue sections were cut at
5 μm thickness using a microtome, dewaxed and
stained with haematoxylin and eosin (H&E), periodic
acid-Schiff (PAS) and Masson’s trichrome stains.
Renal morphology changes within the glomeruli and
interstitial areas were assessed with the aid of a Nikon
Eclipse 80i light microscope, using a semi quantitative
scoring method [20,21].Immunohistochemistry
Renal tissue was sectioned into 5 μm thickness using a ro-
tary microtome and placed onto poly-L-lysine coated
slides. For antigen retrieval, specimen slides were trans-
ferred to 10 mmol l−1 citrate buffer solution (pH 6.0) and
then heated in decloaking chamber at 120°C for 20 min.
Subsequently, the sections were incubated with Dako
Real™ Peroxidase blocking solution for 10 min and rinsed
with phosphate buffer saline (PBS) (pH 7.4). The sections
were incubated with primary antibodies recognising
p22phox (1:200) and p67phox (1:100) for 1 h at room
temperature. The sections were rinsed with PBS (pH 7.4)
and were incubated with horseradish peroxidase (HRP)
rabbit/mouse secondary antibody (Dako Real™ Envision™)
for 30 min at room temperature. For coloration, the slides
were incubated with a mixture of Dako Real™DAB
Chromogen and Dako Red™ substrate buffer (1:50) for 5
min at room temperature. Sections were finally counter-
stained with hematoxylin. Representative areas of renal
morphology changes within the glomeruli and interstitial
areas were photographed using a Nikon Eclipse 80i light
microscope.Western blotting
Homogenised samples from the renal cortex were sepa-
rated on 4-20% sodium dodecyl sulphate (SDS-PAGE)
gels and the proteins were transferred to polyvinylidene
fluoride (PVDF) membrane. The membranes were
blocked with 5% non-fat milk followed by primary anti-
bodies recognising p22phox and p67phox (1:500), and
incubated at 4°C overnight. The membranes were
washed and incubated with HRP-conjugated goat
antirabbit IgG. Band densities were normalised to the
total amount of protein loaded in each well, as deter-
mined by densitometric analysis of PVDF membranes
stained with Amersham ECL Prime Western Blotting
Detection Reagent (GE Healthcare). The proteins were
visualised by chemiluminescence (UVP, Bio Spectrum,
USA) and the densities of specific bands were quanti-
tated by densitometry using Vision Work LS software
(Version: 7.1 RC3.10). Housekeeping protein β-actin
(1:1000) was used as loading control.Statistical analysis
Data are shown as mean ± SEM. The mean values were
compared among the 3 groups using one way analysis of
variance (ANOVA), followed by Tukeys Multiple Com-
parison Test (Graph Pad Prism). Experimental differ-
ences were considered statistically significant if P < 0.05.Results
Effect of OPLE on metabolic parameters
The effects of OPLE on body and kidney weights, ran-
dom blood glucose level and mean arterial pressure in
C, DC and D +OPLE 1000 mg kg−1 are shown in Table 1.
The mean body weight of DC group was 1.2 and 1.8 fold
lower than the C group on the 4th and 12th week after
diabetes induction respectively; however the difference
was significant (P < 0.01) only in the 12-week study. In
contrast, kidney weight normalised by 100 g body weight
of the DC group was significantly heavier than that of
the corresponding C group by 1.4 fold (P < 0.01) on the
4th week. Similar result was obtained with DC group as
compared to the corresponding C group on the 12th
week (2.2 fold, P < 0.001). However, diabetic rats treated
with 1000 mg kg−1 OPLE did not show any significant
changes in mean body weight and kidney to body weight
ratio for both the 4-week and 12-week experimental
studies.
Random glucose levels in the whole blood of DC rats
were significantly higher than that of the C rats at both
4 (6.6 fold, P < 0.001) and 12 weeks (5 fold, P < 0.001)
after diabetes induction. OPLE (1000 mg kg−1) treat-
ment of diabetic animals for either 4 or 12 weeks did
not show any improvement in the random glucose level
(Table 1).
Table 1 Effects of OPLE on body and kidney weights, random blood glucose level and mean arterial pressure
Control Diabetes control Diabetes + OPLE 1000 mg kg-1
4 weeks 12 weeks 4 weeks 12 weeks 4 weeks 12 weeks
Body weight (g) 365.0 ± 14.3 428.3 ± 13.0 309.2 ± 25.4 235.0 ± 14.6aaa 291.7 ± 32.8 266.7 ± 15.2aaa
Kidney weight (g 100 g−1 body weight) 0.40 ± 0.01 0.32 ± 0.02 0.57 ± 0.03aa 0.69 ± 0.02aaa 0.56 ± 0.04aa 0.64 ± 0.03aaa
Glucose level (mmol l−1) 4.7 ± 0.1 6.3 ± 0.2 30.7 ± 1.7aaa 31.0 ± 1.2aaa 27.0 ± 2.3aaa 31.7 ± 0.8aaa
Mean arterial pressure (mmHg) 113.2 ± 2.1 111.5 ± 2.9 115.3 ± 3.2 116.7 ± 3.3 115.0 ± 2.8 114.2 ± 2.5
Data are expressed as mean ± SEM of six experiments for each group. aaP < 0.01; aaaP < 0.001 vs. corresponding control.
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Renal blood flow (RBF) of various groups in the present
study is listed in Table 2. RBF did not differ among the
three study groups at 4 weeks. Conversely, RBF was sig-
nificantly increased in DC group compared with the cor-
responding C group at 12 weeks (1.5-fold, P < 0.001) and
OPLE at 1000 mg kg−1 did not normalise the RBF in the
diabetic group.
It is well established that early stages of DN are associ-
ated with hyperfiltration, both clinically and experimen-
tally. Glomerular filtration rate (GFR) in the 4-week DC
group was raised in comparison with the corresponding
C group (1.6-fold, P < 0.001), as evaluated by inulin
clearance (Table 2). Hyperfiltration was prevented by
1000 mg kg−1 OPLE (P < 0.01) in the 4-week study.
Likewise, GFR was significantly greater (1.7-fold, P <
0.05) in the 12-week DC rats than in the corresponding C
rats. But OPLE treatment at 1000 mg kg−1 of diabetic ani-
mals for 12 weeks further increased the GFR (P < 0.05),
signifying further renal dysfunction.
Renal excretory function
The urine flow rate (UFR) of the DC rats was remark-
ably increased in comparison to C rats on both the 4th
week (2.8 fold, P < 0.001) and 12th week (2.7 fold, P <
0.001) and this occurrence may be the outcome of
hyperfiltration (Table 2). OPLE at 1000 mg kg−1 admin-
istered over a period of 4 weeks almost prevented the in-
crease in UFR in diabetic rats (P < 0.01). However, when
the same dose of OPLE was administered over a period
of 12 weeks to diabetic animals, UFR was further in-
creased (P < 0.01).Table 2 Effect of OPLE on renal functional parameters
Control
4 weeks 12 weeks
Renal blood flow (ml min−1 g−1 kidney) 1.43 ± 0.10 1.66 ± 0.15
Glomerular filtration rate (ml min−1 g−1 kidney) 0.61 ± 0.06 0.47 ± 0.06
Urine flow rate (μl min−1 g−1 kidney) 3.75 ± 0.59 2.72 ± 0.36
Urinary protein excretion (mg 2hr−1) 1.33 ± 0.03 1.08 ± 0.02
Fractional sodium excretion (%) 0.63 ± 0.19 0.50 ± 0.08
Data are expressed as mean ± SEM of six experiments for each group. aP < 0.05; aaP < 0
corresponding diabetes control.Protein excretion in the urine indicates damage to
glomerular barrier, thus urinary protein excretion was
measured in the three experimental groups (Table 2).
Urinary protein excretion was increased significantly in
DC rats compared with C rats in both the 4-week (5-
fold, P < 0.001) and 12-week (3.4-fold, P < 0.01) studies.
Proteinuria induced by diabetes was significantly re-
duced by 1000 mg kg−1 OPLE administered over a
period of 4 weeks (P < 0.001). On the contrary, when the
extract was administered for 12 weeks to diabetic ani-
mals, proteinuria was aggravated (P < 0.01), indicating
more renal damage.
Fractional sodium excretion was evaluated to assess
tubular function. However, our study did not show any
differences amongst the three experimental groups in
both the 4-week and 12-week studies (Table 2).
Effect of OPLE on oxidative stress
Oxidative stress was assessed by estimating the forma-
tion of oxidative damage products or endogenous end-
products of ROS in plasma, urine and renal cortex of
the STZ-diabetes induced rats to address the effect of
OPLE on oxidative stress.
8-Hydroxy-2-deoxy guanosine (8-OHdG)
In this study, we examined the oxidative DNA damage
in kidneys of STZ-induced diabetic rats by measuring
the levels of 8-OHdG in urine samples. Urinary 8-
OHdG levels were significantly greater in DC rats than
in C rats on the 4th week (22.56 ± 3.51 ng 2 h−1 vs. 7.77 ±
0.93 ng 2 h−1, P < 0.01) and the 12th week (23.91 ± 3.58 ng
2 h−1 vs. 5.68 ± 0.95 ng 2 h−1, P < 0.001) after diabetesDiabetes control Diabetes + OPLE 1000 mg kg-1
4 weeks 12 weeks 4 weeks 12 weeks
2.28 ± 0.39 2.49 ± 0.17aaa 1.73 ± 0.32 2.52 ± 0.19aaa
0.96 ± 0.04aaa 0.80 ± 0.05a 0.62 ± 0.06bb 1.06 ± 0.14aaa,b
10.68 ± 1.30aaa 7.32 ± 0.57aaa 5.40 ± 0.68bb 10.88 ± 0.98aaa,bb
6.83 ± 0.30aaa 3.72 ± 0.30aa 1.77 ± 0.17bbb 5.99 ± 0.44aaa,bb
1.34 ± 0.34 0.91 ± 0.20 1.77 ± 0.17bbb 5.99 ± 0.44aaa,bb
.01; aaaP < 0.001 vs. corresponding control; bP < 0.05, bbP < 0.01, bbbP < 0.001 vs.
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mg kg−1 OPLE to diabetic rats for 4 weeks significantly
reduced urinary 8-OHdG levels (12.23 ± 0.75 ng 2 h−1,
P < 0.05) when compared to DC rats. In contrast, 1000
mg kg−1 OPLE given to diabetic rats for 12 weeks further
raised the urinary 8-OHdG level (30.14 ± 0.75 ng 2 h−1) as
compared to DC rats; however the difference is not
significant.
Lipid peroxides (LPO)
Renal cortical LPO were significantly higher in DC rats
than in C rats at both 4 weeks (3.88 ± 0.15 nmols mg−1
protein vs. 2.48 ± 0.14 nmols mg−1 protein, P < 0.001)
and 12 weeks (5.68 ± 0.44 nmols mg−1 protein vs. 2.75 ±
0.14 nmols mg−1 protein, P < 0.001) after diabetes induc-
tion as shown in Figure 2. Significant reduction of renal
cortical LPO levels was observed in the D +OPLE 1000
mg kg−1 group (2.76 ± 0.07 nmols mg−1 protein, P < 0.001)
in the 4-week study but in the 12-week study, the D +
OPLE 1000 mg kg−1 rats showed further increase in LPO
levels (7.86 ± 0.46 nmols mg−1 protein, P < 0.001) when
compared to DC rats; indicating that prolonged adminis-
tration of 1000 mg kg-1 OPLE over a period of 12 weeks
aggravate renal oxidative stress.
Glutathione (GSH)
GSH is a component of the endogenous antioxidant de-
fence system and it plays a major role in scavenging
hydrogen peroxide (H2O2) under physiological condi-
tions. The measurement of renal GSH content was
performed to establish the effect of OPLE on endogen-
ous antioxidant defence system in diabetes. As demon-
strated in Figure 3, the reduction in renal cortical GSH
content was significantly improved by 1000 mg kg−1 OPLE












































Figure 1 Effect of OPLE on urinary 8-OHdG concentration in the 4-we
per group). aaP < 0.01; aaaP < 0.001 vs. corresponding control; bP < 0.05 vs. cornmols mg−1 protein vs. 2.98 ± 0.13 nmols mg−1 protein,
P < 0.05). But when 1000 mg kg−1 OPLE was adminis-
tered to diabetic rats for 12 weeks, there was further re-
duction, albeit not significant, of renal GSH (2.30 ± 0.15
nmols mg−1 protein vs. 2.93 ± 0.28 nmols mg−1 renal
GSH in DC rats).
Effect of OPLE on plasma transforming growth factor
beta-1 (TGF- β1)
In accordance with renal dysfunction and the increased
markers of oxidative stress (urinary 8-OHdG excretion
and renal cortical LPO), significantly higher concentra-
tions of TGF-β1 were detected in plasma of DC rats
than in C rats on both the 4th week (17.09 ± 1.10 pg ml−1
vs. 12.09 ± 0.75 pg ml−1, P < 0.01) and 12th week (20.34 ±
0.96 pg ml−1 vs. 13.29 ± 0.85 pg ml−1, P < 0.01) after dia-
betes induction, as shown in Figure 4. When 1000 mg
kg−1 OPLE was administered to diabetic animals for 4
weeks, a significant reduction in plasma TGF-β1 concen-
trations was observed as compared to DC rats (12.09 ±
0.82 pg ml−1, P < 0.01). On the other hand, when the ex-
tract was administered for an extended period i.e. 12
weeks to diabetic animals, a further increase in TGF-β1
concentrations was observed in comparison to DC rats
(26.42 ± 1.4 pg ml−1, P < 0.01); indicating that more fi-
brotic changes within the kidney might have occurred.
Effect of OPLE on renal morphology
The photomicrographs of haematoxylin and eosin
(H&E) staining of renal tissues of control and experi-
mental groups of rats are shown in Figure 5i(A, B).
Renal tissue sections of C rats demonstrated normal
architecture with normal glomeruli and tubules. Renal
sections from DC rats exhibited glomerular injury, tubular

























































































































































Figure 2 Effect of OPLE on renal cortical LPO concentration in the 4-week (A) or 12-week (B) study. Data are expressed as mean ± SEM
(n = 6 per group). aaaP < 0.001 vs. corresponding control; bbP < 0.01, bbbP < 0.001 vs. corresponding diabetes control.
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logical changes were detected in kidney of diabetic animals
treated 1000 mg kg-1 OPLE for 4 weeks and the sections
were comparable to C rats. Diabetic animals treated with
the extract for 12 weeks however revealed more severe
damage than the DC rats.
PAS-stained sections of the renal cortex 4 weeks after
diabetes induction (Figure 5iiA) exhibited marked glo-
merulosclerosis, characterized by glomerular basement
membrane thickening and mesangial expansion with
glomerular hypertrophy, in comparison with C rats. Re-
markably, treatment with 1000 mg kg-1OPLE for 4
weeks reduced glomerulosclerosis and attenuated the



















































Figure 3 Effect of OPLE on kidney (renal cortex) GSH concentration in
SEM (n = 6 per group). aaP < 0.01, aaaP < 0.001; vs. corresponding control; bP <Morphometric analysis revealed a significant reduction
in the mesangial area in the D +OPLE 1000 mg kg−1 rats
and the data clearly demonstrates that OPLE treatment
alleviated the mesangial expansion (P < 0.05, Table 3).
Twelve weeks of oral administration of the extract how-
ever did not resolve the diabetes-induced renal damage,
if anything there was worsening of renal injury, albeit
not significant in comparison to DC rats (Figure 5iiB,
Table 3).
Masson's trichrome-stained sections of diabetic kidney
on week 4 exhibited increased collagen deposition, tubular
dilation, and degeneration of cortical tubules (Figure 5iiiA)
whilst these changes were not apparent in the C rat’s kid-



















































the 4-week (A) or 12-week (B) study. Data are expressed as mean ±

























































































Figure 4 Effect of OPLE on plasma TGF-β1 concentration in the 4-week (A) or 12-week (B) study. Data are expressed as mean ± SEM (n = 6
per group). aaP < 0.01; aaaP < 0.001 vs. corresponding control; bP < 0.05, bbP < 0.01 vs. corresponding diabetes control.
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cortex and medulla was observed in diabetic kidney on
week 12 (Figure 5iiiB). There was capillary occlusion, in-
creased proliferation of interstitial fibroblasts, tubular dila-
tation and atrophy whereas no apparent changes were
detected in kidney of C rats. Treatment with 1000 mg kg−1
OPLE for 4 weeks showed a reduction in tubulointerstitial
fibrosis in comparison to DC rats (P < 0.05, Table 3). But
diabetic animals treated with 1000 mg kg−1 OPLE for 12
weeks instead showed further increase in tubulointerstitial
fibrosis, capillary occlusion, proliferation of interstitial fi-
broblasts, tubular dilatation and atrophy in comparison to
DC rats, although morphometric analysis showed no sig-
nificant difference (Figure 5iiiB, Table 3).
NADPH oxidase subunit immunolocalisation and
protein expression
To examine the localisation and expression of p22phox
and p67phox proteins in the rat kidney, we carried out
immunostaining analysis 4 and 12 weeks after onset of
diabetes. Immunohistochemical staining of the NADPH
oxidase subunits p22phox and p67phox revealed wide-
spread staining in the glomeruli (Figures 6iA and iiA),
which is similar in distribution to that of previously ob-
served in the normal rat’s kidney [22]. The expression of
glomerular p22phox and p67phox was increased with
diabetes and ameliorated by treatment with 1000 mg kg-1
OPLE for 4 weeks but not by treatment with the extract
for 12 weeks. Western blot analysis confirmed that
p22phox and p67phox proteins were up-regulated signifi-
cantly in diabetic kidney on the 4th week (2.5 and 2.7 folds
of C rats respectively, P < 0.01) and on the 12th week (3
and 3.1 folds of C respectively, P < 0.01). Both the NADPH
oxidase subunits elevation was reduced by 1000 mg kg−1
OPLE in diabetic kidneys on the 4th week (P < 0.05,Figures 7iA-ivA). When treatment with the extract was
extended to 12 weeks, both the NADPH oxidase subunits
in the diabetic kidney were instead further increased, and
the difference was significant only for the p22phox subunit
(P < 0.05, Figure 7iB-ivB).
Discussion
The effects of OPLE in diabetic nephropathy (DN)
The present study was conducted to investigate the anti-
oxidant and pro-oxidant effects of chronically adminis-
tering high dose of OPLE (1000 mg kg-1) in an animal
model of DN. Oxidative stress has been considered to be
a general pathogenic factor of diabetic complications in-
cluding nephropathy [3,4]. Our current data demon-
strated that oral administration with high dose of
catechins-rich OPLE (1000 mg kg-1) to STZ-induced
diabetic rats for 4 weeks attenuated renal dysfunction
(hyperfiltration, proteinuria) and development of glomeru-
losclerosis and tubulointerstitial fibrosis, features that are
associated with DN [23]. Concomitant with the beneficial
effects of OPLE, we observed a suppression of the in-
creases in oxidative stress markers (8-OHdG, LPO) and
the fibrotic cytokine, TGF-β1. Our data confirmed the pre-
viously reported findings that oral administration albeit
with lower doses of OPLE (200 mg kg-1 and 500 mg kg-1)
for 4 weeks similarly attenuated renal dysfunction and
renal pathology associated with DN in the STZ-induced
diabetic rat due to the antioxidant effect of the extract [5].
In contrast and most interestingly, our study revealed that
when oral administration of 1000 mg kg-1 OPLE was ex-
tended for 12 weeks, no renoprotection was detected in
the diabetic animals. In fact, worsening of renal dysfunc-
tion as evidenced by further increase in hyperfiltration
and proteinuria were observed in these diabetic rats.
Moreover, oxidative stress markers (LPO) and TGF-β1
Figure 5 Effect of OPLE on renal morphology. Histological sections of kidneys stained with (i) haematoxylin and eosin; (ii). Periodic acid-Schiff
(PAS); (iii). Masson’s trichrome in the 4-week (A) or 12-week (B) study. Control (C), Diabetes Control (DC), Diabetes + OPLE 1000 mg kg−1
(D+OPLE 1000); G, glomerulus; pt, proximal tubule; Bar = 50 μm.
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of OPLE for 12 weeks as compared to the untreated dia-
betic rats possibly indicating pro-oxidant effect of OPLE. In
corroboration, structural damage was amplified, although
not significantly. It is noteworthy that our previous studywith lower doses of OPLE (200 mg kg-1 and 500 mg kg-1)
treated daily for the same duration (12 weeks) however
provided optimal renoprotection in rats with DN in con-
junction with suppression of the increases in oxidative
stress markers [5].
Table 3 Effects of OPLE on renal structure
Control Diabetes control Diabetes + OPLE 1000 mg kg-1
4 weeks 12 weeks 4 weeks 12 weeks 4 weeks 12 weeks
Glomerulosclerotic index 0.23 ± 0.03 0.34 ± 0.03 1.14 ± 0.06a 1.36 ± 0.04aa 0.68 ± 0.06a,b 1.62 ± 0.03aa
Tubulointerstitial fibrosis index 0.49 ± 0.05 0.61 ± 0.06 2.48 ± 0.18a 2.75 ± 0.16aa 1.03 ± 0.08b 3.05 ± 0.07aa
Data are expressed as mean ± SEM of six experiments for each group. aP < 0.05; aaP < 0.01; vs. corresponding control; bP < 0.05, vs. corresponding diabetes control.
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In the present study, to explore the underlying molecular
mechanisms with the aim of elucidating at least part of
the antioxidant property of OPLE, we examined the effects
of the extract on the renal expression of NADPH oxidase
subunits, p22phox and p67phox. It is well established that
oxidative stress has been implicated in the pathogenesis of
renal injury in diabetes mellitus and the NADPH oxidase
is an important source of ROS production [3,24,25]. The
NADPH oxidase consists of membrane-bound subunits
(p22phox and Nox4, a renal homologue of gp91phox) andFigure 6 NADPH oxidase subunits immunolocalization in the kidney.
of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunit
Control (C), Diabetes Control (DC) and Diabetes + OPLE 1000 mg kg−1 (D +
Bar = 50 μm.cytosolic subunits (p47phox, p40phox, p67phox, and Rac)
[26,27]. Previous studies suggested that one of the mecha-
nisms contributing to increased oxidative stress in the dia-
betic kidney is increased expression of NADPH subunits,
namely p22phox, p47phox, p67phox and Nox4 [1,22,28].
In consistent with these reports, we demonstrated through
western blotting and immunohistochemistry that the renal
expression of the membrane-bound subunit p22phox and
the cytosolic subunit p67phox were enhanced in rats with
4 and 12 weeks diabetes respectively. A significant finding
in this study was that administration of OPLE at 1000 mgImmunohistochemical staining of kidney section showing localization
(i) p22phox and (ii) p67phox in the 4-week (A) or 12-week (B) study.
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C                          DC          D+OPLE 1000 C                                 DC          D+OPLE 1000 
Figure 7 NADPH oxidase subunits protein expression in the kidney. Effect of OPLE on renal protein expressions of p22phox and p67phox
NADPH oxidase subunit 4-week (A) or 12-week study (B). (i and iii) Representative western blots showing bands of p22phox, p67phox and β-actin as
an internal control. Control (C), Diabetes Control (DC) and Diabetes + OPLE 1000 mg kg−1 (D + OPLE 1000); (ii and iv) Densitometric analysis of protein
renal expression of p22phox and p67phox NADPH oxidase subunits. Data are expressed as mean ± SEM of four experiments for each group. aP < 0.05;
aaP < 0.01; vs. corresponding control; bP < 0.05, vs. corresponding diabetes control.
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regulation of both subunits and this effect was independ-
ent of changes in blood sugar. We therefore hypothesise
that inhibition of NADPH oxidase, the enzyme that is in-
volved in formation of O2
.-, may in part contribute to the
antioxidant effect of OPLE. Studies have adduced evidence
that catechins and their metabolites were capable ofprotecting vascular endothelial cells against O2
.- through
inhibition of endothelial NADPH oxidase activity [29].
OPLE is rich in catechins such as epigallocatechin, cat-
echin, epicatechin, epigallocatechin gallate and epicatechin
gallate [10], and inhibition of NADPH oxidase in the
present study in all probability could be due to the actions
of these catechins, although other compounds such as
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also play a role. Indeed, ferulic acid has been shown to
have higher NADPH oxidase-inhibitory potency than
apocynin [29].
Increase endogenous antioxidant by OPLE
The present study also demonstrated that OPLE en-
hanced endogenous antioxidant enzyme as one of the
mechanisms to reduce diabetes-induced oxidative renal
damage. Diabetic rats given 1000 mg kg-1 OPLE over a
period of 4 weeks exhibited increased levels of GSH.
Similarly, tea administration of which catechins are
major components, prevented depletion in rats’ liver
GSH induced by carbon tetrachloride or ethanol [30,31].
Pro-oxidant property of OPLE
Our data clearly suggest that there is more than one
mechanism that may contribute to the antioxidant effect
of OPLE which could be beneficial in abrogating indices
of DN. The beneficial effects of antioxidants mainly spot-
light on their defensive functions against undue oxidative
damage induced by ROS. However, from a health perspec-
tive one must be conscious that a powerful antioxidant
could also exhibit pro-oxidant performance, leading to
oxidative damage of cellular mechanism [16,32]. Indeed,
what is intriguing in our present study was the unmasking
of the pro-oxidant effect of OPLE when 1000 mg kg-1 of
the extract was given to diabetic rats for an extended
period i.e. 12 weeks as opposed to 4 weeks. We are not
certain of the mechanisms that trigger the transition of
OPLE antioxidant effect to the pro-oxidant effect when
administered for a longer duration; however our findings
showed increase expression of the NADPH subunits,
p22phox (significant) and p67phox (non-significant) when
1000 mg kg-1 OPLE was administered to diabetic animals
for 12 weeks. Aggravation of renal dysfunction and struc-
tural injury by the high dose of OPLE administered to dia-
betic animals for 12 weeks in the present study is
purported to be due to the pro-oxidant effect of OPLE but
we would not exclude some other unknown ways. Szeto
et al. [33] reported that 200 μM epigallocatechin and
epigallocatechin gallate induced oxidative damage in
human DNA due to the production of hydrogen per-
oxide. Green tea extract (10–200 μg ml-1) which con-
tain catechins similar to OPLE, and epigallocatechin
gallate (20–200 μM) have also been shown to exacer-
bate oxidant activity, oxidative stress, genotoxicity and
cytotoxicity induced by hydrogen peroxide in RAW
264.7 macrophages [34].
Conclusion
The antioxidant/pro-oxidant properties of OPLE could be
important in determining the functional outcome of a cell,
and the biological response could either be beneficial orharmful, depending on the oxidative condition existing
within a cell. Taken together, the findings of our study in-
dicate that chronic administration of 1000 mg kg-1 OPLE
exerts both antioxidant and pro-oxidant effects depending
on the duration of treatment as assessed by levels of oxi-
dative stress markers, renal dysfunction and renal path-
ology in DN. Furthermore, our study provides some
mechanistic insight into the antioxidant and pro-oxidant
effects of OPLE. Ultimately, our findings stress the import-
ance of conducting a careful dose–response and treatment
duration studies for OPLE before excessive intake of the
product can be recommended to diseased individuals
where oxidative stress plays a major role.
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